ALK and lung adenocarcinoma: In western countries, rearrangements in the gene (ALK) encoding anaplastic lymphoma receptor tyrosine kinase have been found in only 3–7% of lung adenocarcinomas; in contrast, EGFR mutation is approximately 10–15%, more frequent than ALK rearrangement [1, 2].